Verdence Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,440
Closed -$471K 685
2025
Q4
$471K Buy
4,440
+71
+2% +$8.23K 0.03% 444
2025
Q3
$556K Buy
4,369
+57
+1% +$6.79K 0.03% 414
2025
Q2
$529K Sell
4,312
-985
-19% -$113K 0.04% 398
2025
Q1
$536K Buy
5,297
+1,696
+47% +$166K 0.04% 365
2024
Q4
$333K Sell
3,601
-69
-2% -$6.78K 0.03% 481
2024
Q3
$355K Buy
3,670
+160
+5% +$14.4K 0.03% 470
2024
Q2
$301K Sell
3,510
-1,977
-36% -$166K 0.03% 465
2024
Q1
$453K Sell
5,487
-74
-1% -$5.42K 0.04% 365
2023
Q4
$371K Sell
5,561
-19
-0.3% -$1.23K 0.04% 403
2023
Q3
$375K Buy
5,580
+370
+7% +$25.4K 0.04% 379
2023
Q2
$353K Sell
5,210
-488
-9% -$30.6K 0.04% 379
2023
Q1
$308K Buy
5,698
+183
+3% +$10.7K 0.04% 414
2022
Q4
$330K Sell
5,515
-160
-3% -$8.7K 0.04% 361
2022
Q3
$257K Sell
5,675
-1,319
-19% -$66K 0.04% 422
2022
Q2
$312K Sell
6,994
-270
-4% -$13.9K 0.04% 371
2022
Q1
$411K Buy
7,264
+914
+14% +$47.7K 0.05% 335
2021
Q4
$330K Buy
6,350
+2,443
+63% +$126K 0.04% 385
2021
Q3
$233K Sell
3,907
-262
-6% -$16.5K 0.03% 440
2021
Q2
$259K Sell
4,169
-1,330
-24% -$88.6K 0.04% 404
2021
Q1
$358K Buy
5,499
+549
+11% +$35.8K 0.06% 304
2020
Q4
$326K Sell
4,950
-106
-2% -$6.24K 0.06% 265
2020
Q3
$261K Sell
5,056
-30
-0.6% -$1.54K 0.06% 279
2020
Q2
$251K Buy
5,086
+336
+7% +$18.1K 0.06% 274
2020
Q1
$242K Buy
4,750
+1,043
+28% +$60.1K 0.07% 242
2019
Q4
$204K Buy
+3,707
New +$201K 0.05% 306

Other funds holding EHC

Verdence Capital Advisors's EHC Position: Q1 2026 in Review

Verdence Capital Advisors sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 4,440 shares — an estimated $471K sold.

Verdence Capital Advisors first reported a position in EHC in Q4 2019 and held it in 25 quarters. The position peaked at $556K in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Verdence Capital Advisors reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Verdence Capital Advisors sold 4,440 Encompass Health shares in Q1 2026, an estimated $471K.
  • Verdence Capital Advisors first reported a position in Encompass Health in Q4 2019 and held it in 25 quarters.
  • Verdence Capital Advisors's Encompass Health position peaked at $556K in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.